Ardent Health, Inc. (ARDT) Expands Footprint with 18 New Urgent Care Clinics in 2025

We recently compiled a list of the 10 Overlooked Healthcare Stocks to Invest in. Ardent Health, Inc. is one of them.

Ardent Health, Inc. (NYSE:ARDT), one of the most overlooked stocks, is rapidly expanding its presence in the U.S. healthcare market, focusing on outpatient and ambulatory care through urgent care centers and digital innovations. Operating 30 hospitals and over 280 sites of care across eight states, the company targets mid-sized urban markets with a consumer-focused model that integrates physical and virtual care.

In 2025, Ardent Health, Inc. (NYSE:ARDT) significantly increased its reach by acquiring 18 urgent care clinics in New Mexico and Oklahoma, with plans to add five more urgent care centers and two imaging centers by year-end. The rollout of digital tools, including virtual nursing, AI-enabled scribe technology, and medical wearables, has improved patient outcomes while reducing costs and nurse turnover. The corporation is also developing new ambulatory surgery centers (ASCs) to meet growing demand, emphasizing de novo facility construction alongside acquisitions.

Ardent Health, Inc. (NYSE:ARDT) is expanding cancer care services within its network, exemplified by integrating the Hillcrest Medical Center oncology and infusion clinic into the OU Health Stephenson Cancer Center at Hillcrest. This initiative enhances access to comprehensive oncology services, supports academic-clinical collaboration, and strengthens the continuum of care for cancer patients.

While we acknowledge the potential of ARDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.